BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| IgA nephropathy (IgAN) |
📓
Microbiota and metabolome associated with immunoglobulin A nephropathy (IgAN). PloS one (PLoS One ) Vol: 9 Issue 6 Pages: e99006 Pub: 2014 Epub: 2014 Jun 12 Authors De Angelis M , Montemurno E , Piccolo M , Vannini L , Lauriero G , Maranzano V , Gozzi G , Serrazanetti D , Dalfino G , Gobbetti M , Gesualdo L , Html Article Publication |
| IgA nephropathy (IgAN) |
📓
Gut Microbiome Characteristics in IgA Nephropathy: Qualitative and Quantitative Analysis from Observational Studies. Frontiers in cellular and infection microbiology (Front Cell Infect Microbiol ) Vol: 12 Issue Pages: 904401 Pub: 2022 Epub: 2022 May 17 Authors Han S , Shang L , Lu Y , Wang Y , Html Article Publication |
| IgA nephropathy (IgAN) |
📓
The Gut and Blood Microbiome in IgA Nephropathy and Healthy Controls. Kidney360 (Kidney360 ) Vol: 2 Issue 8 Pages: 1261-1274 Pub: 2021 Aug 26 Epub: 2021 Jun 9 Authors Shah NB , Nigwekar SU , Kalim S , Lelouvier B , Servant F , Dalal M , Krinsky S , Fasano A , Tolkoff-Rubin N , Allegretti AS , Html Article Publication |
| IgA nephropathy (IgAN) |
📓
Potential Roles of Oral Microbiota in the Pathogenesis of Immunoglobin A Nephropathy. Frontiers in cellular and infection microbiology (Front Cell Infect Microbiol ) Vol: 11 Issue Pages: 652837 Pub: 2021 Epub: 2021 Apr 2 Authors He JW , Zhou XJ , Hou P , Wang YN , Gan T , Li Y , Liu Y , Liu LJ , Shi SF , Zhu L , Lv JC , Zhang H , Html Article Publication |
| IgA nephropathy (IgAN) |
📓
Associations of Genetic Variants Contributing to Gut Microbiota Composition in Immunoglobin A Nephropathy. mSystems (mSystems ) Vol: 6 Issue 1 Pages: Pub: 2021 Jan 12 Epub: 2021 Jan 12 Authors He JW , Zhou XJ , Li YF , Wang YN , Liu LJ , Shi SF , Xin XH , Li RS , Falchi M , Lv JC , Zhang H , Html Article Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
